MeSH term
Frequency | Condition_Probility | Adolescent | 2 | 0.0 |
Adult | 7 | 0.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Child | 4 | 0.0 |
Humans | 30 | 0.0 |
Middle Aged | 8 | 0.0 |
Animals | 8 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Phenylpropionates/*pharmacology | 2 | 40.0 |
Recurrence | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
Female | 12 | 0.0 |
*Gastrointestinal Transit | 2 | 40.0 |
Male | 12 | 0.0 |
Rats | 2 | 0.0 |
Receptor, Endothelin A | 2 | 7.0 |
Base Sequence | 3 | 0.0 |
Cell Line | 4 | 0.0 |
DNA Primers | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Laminin/metabolism | 2 | 1.0 |
Phenotype | 3 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Cell Adhesion Molecules/*metabolism | 2 | 0.0 |
Mice | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Alleles | 2 | 0.0 |
Isoantibodies/immunology | 2 | 4.0 |
Multigene Family | 2 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Blood Group Antigens/*genetics | 4 | 3.0 |
DNA, Complementary/genetics | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Time Factors | 2 | 0.0 |
